Synergistic effects of glutaminase and proteasome inhibition in multiple myeloma cell lines

被引：0
|
作者：
Viswanadha, Srikant [1 ]
Eleswarapu, Satyanarayana [1 ]
Penmetsa, Kumar V. [2 ]
Vakkalanka, Swaroop [2 ]
机构：
[1] Incozen Therapeut Pvt Ltd, Shameerpet Hyderabad, India
[2] Rhizen Pharmaceut, La Chaux De Fonds, Switzerland
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1889
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1889
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Molecular sequelae of proteasome inhibition in human multiple myeloma cells
    Mitsiades, N
    Mitsiades, CS
    Poulaki, V
    Chauhan, D
    Fanourakis, G
    Gu, XS
    Bailey, C
    Joseph, M
    Libermann, TA
    Treon, SP
    Munshi, NC
    Richardson, PG
    Hideshima, T
    Anderson, KC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14374 - 14379
  • [32] The proteasome and proteasome inhibitors in multiple myeloma
    Sara Gandolfi
    Jacob P. Laubach
    Teru Hideshima
    Dharminder Chauhan
    Kenneth C. Anderson
    Paul G. Richardson
    Cancer and Metastasis Reviews, 2017, 36 : 561 - 584
  • [33] The proteasome and proteasome inhibitors in multiple myeloma
    Gandolfi, Sara
    Laubach, Jacob P.
    Hideshima, Teru
    Chauhan, Dharminder
    Anderson, Kenneth C.
    Richardson, Paul G.
    CANCER AND METASTASIS REVIEWS, 2017, 36 (04) : 561 - 584
  • [34] Small molecule inhibition of proteasome and aggresome function induces synergistic anti-tumor activity in multiple myeloma.
    Hideshima, T
    Bradner, JE
    Wong, J
    Chauhan, D
    Richardson, PG
    Schreiber, SL
    Anderson, KC
    BLOOD, 2005, 106 (11) : 450A - 451A
  • [35] METABOLIC EFFECTS OF A GLUTAMINASE INHIBITOR ON GLIOMA CELL LINES
    Rodado, Victor Ruiz
    Saldana, Alejandra Cavazos
    Movva, Sriya
    Lita, Adrian
    Dowdy, Tyrone
    Gilbert, Mark R.
    Larion, Mioara
    NEURO-ONCOLOGY, 2017, 19 : 129 - 129
  • [36] The effects of proteasome inhibitors on bone remodeling in multiple myeloma
    Zangari, Maurizio
    Suva, Larry J.
    BONE, 2016, 86 : 131 - 138
  • [37] Cardiovascular effects of multiple myeloma therapy with proteasome inhibitors
    Gavazzoni, M.
    Gorga, E.
    Vizzardi, E.
    Raddino, R.
    VASCULAR PHARMACOLOGY, 2018, 103 : 70 - 70
  • [38] Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors
    Besse, Andrej
    Besse, Lenka
    Kraus, Marianne
    Mendez-Lopez, Max
    Bader, Juergen
    Xin, Bo-Tao
    de Bruin, Gerjan
    Maurits, Elmer
    Overkleeft, Herman S.
    Driessen, Christoph
    CELL CHEMICAL BIOLOGY, 2019, 26 (03): : 340 - +
  • [39] Enhanced levels of apoptosis by combination of farnesyl transferase inhibition (tipifarnib) and proteasome inhibition (bortezomib) in myeloma cell lines and primary myeloma cells and its mechanistic effects on Akt and caspase pathways.
    Kaufman, JL
    David, E
    Torre, C
    Sinha, R
    Lonial, S
    BLOOD, 2005, 106 (11) : 451A - 452A
  • [40] Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma
    Kegyes, David
    Gulei, Diana
    Drula, Rares
    Cenariu, Diana
    Tigu, Bogdan
    Dima, Delia
    Tanase, Alina
    Badelita, Sorina
    Buzoianu, Anca-Dana
    Ciurea, Stefan
    Ghiaur, Gabriel
    Terpos, Evangelos
    Ciechanover, Aaron
    Einsele, Hermann
    Tomuleasa, Ciprian
    BLOOD REVIEWS, 2023, 61
12345